Doxycycline for the treatment of paronychia induced by the epidermal growth factor receptor inhibitor cetuximab.
Shu
K-Y
KY
Kindler
H L
HL
Medenica
M
M
Lacouture
M
M
D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D004318:Doxycycline / Q000627:therapeutic use*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D009894:Opportunistic Infections / Q000188:drug therapy*; D010304:Paronychia / Q000139:chemically induced / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D066246:ErbB Receptors; D004318:Doxycycline; D000068818:Cetuximab